Literature DB >> 24767951

Can total knee arthroplasty be safely performed among nonagenarians? An evaluation of morbidity and mortality within a total joint replacement registry.

Alexander Miric1, Maria C S Inacio2, Matthew P Kelly1, Robert S Namba3.   

Abstract

As the nonagenarian patient population continues to grow, more patients aged 90 and over will become candidates for total knee arthroplasty (TKA). This study evaluated the patient characteristics and incidence of postoperative morbidity and mortality of 216 nonagenarian TKA patients among 81,835 primary TKA patients followed by a total joint replacement registry. Nonagenarians had a greater number of comorbidities preoperatively, experienced a higher rate of deep vein thrombosis and 30 day mortality, and had a longer hospital length of stay. However, nonagenarians did not have an increased risk of infection nor pulmonary embolism and postoperative mortality was within expected rates for individuals 90 years and older. Higher readmission rates, however, highlight the benefits of close follow up during a prolonged postoperative period.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  morbidity; mortality; nonagenarian; outcome; readmission; total knee arthroplasty

Mesh:

Year:  2014        PMID: 24767951     DOI: 10.1016/j.arth.2014.03.014

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  8 in total

1.  The utility of machine learning algorithms for the prediction of patient-reported outcome measures following primary hip and knee total joint arthroplasty.

Authors:  Christian Klemt; Akachimere Cosmas Uzosike; John G Esposito; Michael Joseph Harvey; Ingwon Yeo; Murad Subih; Young-Min Kwon
Journal:  Arch Orthop Trauma Surg       Date:  2022-06-29       Impact factor: 3.067

2.  Mortality and complication rates in nonagenarians and octogenarians undergoing total hip and knee arthroplasty: a systematic review and meta-analysis.

Authors:  Dimitrios Kitridis; Konstantinos Tsikopoulos; Panagiotis Givissis; Byron Chalidis
Journal:  Eur Geriatr Med       Date:  2022-01-24       Impact factor: 1.710

3.  Nonagenarians and Octogenarians Undergoing THA and TKA: A 10-Year Age Difference Increases Rates of In-Hospital Complications But Does Not Affect 90-Day Outcomes.

Authors:  Ilan Fleisher; Christian B Ong; Yu-Fen Chiu; Ethan Krell; Fred D Cushner; Elizabeth Gausden; Friedrich Boettner; Alejandro Gonzalez Della Valle
Journal:  HSS J       Date:  2022-05-03

4.  Is simultaneous bilateral total knee arthroplasty safe in geriatric population? A retrospective cohort study with upto 9 years follow up.

Authors:  Raju Vaishya; Vipul Vijay; Kapil Mani K C; Amit Kumar Agarwal
Journal:  J Clin Orthop Trauma       Date:  2017-06-01

5.  What Are Risk Factors for Infection after Primary or Revision Total Joint Arthroplasty in Patients Older Than 80 Years?

Authors:  Nipun Sodhi; Hiba K Anis; Rushabh M Vakharia; Alexander J Acuña; Peter A Gold; Luke J Garbarino; Bilal M Mahmood; Nicholas R Arnold; Joseph O Ehiorobo; Eric L Grossman; Michael A Mont; Martin W Roche
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

6.  Total knee arthroplasty improves the quality-adjusted life years in patients who exceeded their estimated life expectancy.

Authors:  Michele Palazzuolo; Alexander Antoniadis; Jaad Mahlouly; Julien Wegrzyn
Journal:  Int Orthop       Date:  2021-01-15       Impact factor: 3.075

Review 7.  Patient-Related Risk Factors for Unplanned 30-Day Hospital Readmission Following Primary and Revision Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.

Authors:  Daniel Gould; Michelle M Dowsey; Tim Spelman; Olivia Jo; Wassif Kabir; Jason Trieu; James Bailey; Samantha Bunzli; Peter Choong
Journal:  J Clin Med       Date:  2021-01-02       Impact factor: 4.241

8.  How Long Do Octogenarians Benefit From Knee Arthroplasty?

Authors:  Can Doruk Basa; Elcil Kaya Bicer; Semih Aydogdu; Hakki Sur
Journal:  Cureus       Date:  2021-05-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.